Stabilis Calcium gluconate Noms commerciaux
Gluconate de calciumFrance
Stabilité en mélange
3,81 & 8,92 mg/ml
25°C
Magnesium sulfate : 3,81 & 8,92 mg/ml
7
3268
3,81 & 8,92 mg/ml
5°C
Magnesium sulfate : 3,81 & 8,92 mg/ml
7
3268
Facteur influençant la stabilité 3644
Incompatibilités
Calcium gluconate Amikacin sulfate Calcium gluconate Amphotericin B Calcium gluconate : 40 mg/ml Amphotericin B cholesteryl sulfate complex : 0,83 mg/ml Calcium gluconate Amphotericin B cholesteryl sulfate complex Calcium gluconate Atropine sulfate Calcium gluconate Bleomycin sulfate Calcium gluconate Caffeine citrate Calcium gluconate Cefalotin sodium Calcium gluconate Cefamandole nafate
3644 3644 921 3644 3644 3644 3644 3644 1165
www.stabilis.org - 16/01/2017 07:36 - Page 1
Calcium gluconate Cefamandole nafate Calcium gluconate : 2 >> 100 mg/ml Cefamandole nafate Calcium gluconate Cefamandole nafate Calcium gluconate Cefazolin sodium Calcium gluconate Cefpirome sulfate Calcium gluconate : 40 mg/ml Ceftobiprole : 2 mg/ml Calcium gluconate : 40 mg/ml Ceftobiprole : 2 mg/ml Calcium gluconate Ceftriaxone disodium Calcium gluconate Ceftriaxone disodium Calcium gluconate Ceftriaxone disodium Calcium gluconate Chloroquine phosphate Calcium gluconate Chloroquine sulfate Calcium gluconate Clindamycin phosphate Calcium gluconate Clindamycin phosphate Calcium gluconate Dexamethasone sodium phosphate Calcium gluconate : 50 mg/ml Dobutamine hydrochloride : 2 mg/ml Calcium gluconate : 2 mg/ml Dobutamine hydrochloride : 1 mg/ml Calcium gluconate Dobutamine hydrochloride Calcium gluconate Doxycycline hyclate Calcium gluconate Ephedrine sulfate Calcium gluconate Etoposide phosphate Calcium gluconate Fentanyl citrate Calcium gluconate : 2 mg/ml Flucloxacillin sodium : 20 mg/ml Calcium gluconate : 100 mg/ml Fluconazole : 2 mg/ml Calcium gluconate Fludarabine phosphate Calcium gluconate Fosaprepitant
3546 612 3644 3644 3644 2269 2269 2302 3523 3644 3644 3644 3526 3644 3644 1041 1058 3644 3644 3644 3644 3644 1232 496 3644 2295
www.stabilis.org - 16/01/2017 07:36 - Page 2
Calcium gluconate Foscarnet sodium Calcium gluconate Gentamicin sulfate Calcium gluconate Heparin sodium Calcium gluconate : 100 mg/ml Indomethacin sodium trihydrate : 1 mg/ml Calcium gluconate Kanamycin sulfate Calcium gluconate : 40 mg/ml Lansoprazole : 0,55 mg/ml Calcium gluconate Magnesium sulfate Calcium gluconate Magnesium sulfate Calcium gluconate : 4 mg/ml Meropenem : 50 mg/ml Calcium gluconate Minocycline hydrochloride Calcium gluconate Morphine sulfate Calcium gluconate Morphine tartrate Calcium gluconate Netilmicin sulfate Calcium gluconate Pamidronate disodium Calcium gluconate Pantoprazole sodium Calcium gluconate : 40 mg/ml Pemetrexed disodium : 20 mg/ml Calcium gluconate Potassium phosphate Calcium gluconate Potassium phosphate Calcium gluconate Prochlorperazine edysilate Calcium gluconate : 100 mg/ml Propofol Calcium gluconate Protamine sulfate Calcium gluconate Salbutamol sulfate Calcium gluconate Sildenafil citrate Calcium gluconate Sodium bicarbonate Calcium gluconate Sodium citrate Calcium gluconate Sodium Phosphate
3662 3644 1084 467 3644 1625 3838 3644 266 3644 3644 3644 3644 3619 2090 1953 3644 3621 3644 660 3644 3644 3644 3644 3644 3644
www.stabilis.org - 16/01/2017 07:36 - Page 3
Calcium gluconate Streptomycin sulfate Calcium gluconate Sufentanil citrate Calcium gluconate : 20 mg/ml Tedizolid phosphate : 0.8 mg/ml Calcium gluconate Tedizolid phosphate Calcium gluconate Terbutaline sulfate Calcium gluconate : 100 mg/ml Thiopental sodium : 25 mg/ml Calcium gluconate Tigecycline Calcium gluconate Tobramycin sulfate Calcium gluconate Trisodium citrate Calcium gluconate Vinblastine sulfate Calcium gluconate Vincristine sulfate Calcium gluconate Vindesine sulfate
3644 3644 3827 3753 3644 3767 3644 3644 3644 3644 3644 3644
Voie d’administration
Bibliographie
Type 266 Revue
467 Revue
496 Revue
612 Revue
660 Revue
Source Patel PR.
Compatibility of meropenem with commonly used injectable drugs. Am J Health-Syst Pharm 1996 ; 53: 2853-2855. Ishisaka DY, van Vleet J, Marquardt E.
Visual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusion. Am J Hosp Pharm 1991 ; 48: 2442-2443. Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
Frable RA, Klink PR, Engel GL, Mundell EE.
Stability of cefamandole nafate injection with parenteral solutions and additives. Am J Hosp Pharm 1982 ; 39: 622-627. Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232.
www.stabilis.org - 16/01/2017 07:36 - Page 4
921 Revue
Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
1041 Revue
1058 Revue
1084 Revue
1165 Revue
1232 Revue
1625 Revue
1953 Revue
2090 Revue
2269 Revue
2295 Laboratoire 2302 Laboratoire 3268 Revue
3523 Laboratoire 3526 Laboratoire 3546 Laboratoire 3619 Laboratoire 3621 Laboratoire 3644 Laboratoire 3662 Laboratoire
Hosp Pharm 1998 ; 33: 284-292. Hasegawa GR, Eder JF.
Visual compatibility of dobutamine hydrochloride with other injectable drugs. Am J Hosp Pharm 1984 ; 41: 949-951.
Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ.
Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives. Am J Hosp Pharm 1983 ; 40: 1690-1691.
Raupp P, von Kriek R, Schmidt E, Pfahl HG, Günther O.
Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies. Lancet 1988 ; 1(8587): 700.
Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
Compatibility of the cephalosporin, cefamandole nafate with injections. Int J Pharm 1980 ; 4: 263-265. Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293. Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
Fosaprepitant (IV Emend) - Summary of Product Characteristics Merck Sharp Dohme 2013
Ceftriaxone et incompatibilités physico-chimiques, particulièrement avec les solutions contenant des sels de calcium.
Lettre AFSAPS Beauregard N, Bertrand 30 november N, Dufour 2008 A, 2008 Blaizel ; 61, O, 5: 356-357. Leclair G
Physical compatibility of calcium gluconate and magnesium sulfate injections. Am J Health-Syst Pharm 2012 ;69: 98.
Rocephin - Summary of Product Characteristics. Roche 2012
Dalacin C Phosphate - Summary of Product Characteristics Pharmacia 2010
Cefamandole Flavelab - Résumé des caractéristiques du produit. Panpharma SA 2007
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics Actavis 2011
Phosphate dipotassique - Résumé des caractéristiques du produit Renaudin 2008
Calcium gluconate injection® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
www.stabilis.org - 16/01/2017 07:36 - Page 5
3753 Laboratoire
Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
3767 Revue
Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
Cubist Pharmaceuticals 2014
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
3827 Poster
3838 Laboratoire
Pharmactuel 2014 ; 47, 3 : 167-172.
Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedilozid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015 2015
Magnesium Sulphate BP Injection 1g/10ml : Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
www.stabilis.org - 16/01/2017 07:36 - Page 6
Stabilis Calcium gluconate
Stabilité des préparations
Hydroxyéthylcellulose 3 g 2.5 g Calcium gluconate Propylène Glycol 5 g Eau purifiée 87 g
25°C
180
Bibliographie
Type 3017 Revue
Source Rotheli-Simmen B, Martinelli E, Muhlebach S.
Formulation of a stable calcium gluconate gel for topical treatment of hydrofluoric acid burns. Eur Hosp Pharm 1996 ; 2: 176-180.
www.stabilis.org - 16/01/2017 07:36 - Page 7
3017
Dictionnaire Divers
Injectable
Noms commerciaux
Stabilité en mélange
Contenant
Solvant
Concentration
Température
Conservation
Molécule
Heure
Bibliographie
Polyvinyl chlorure
NaCl 0,9% ou glucose 5%
A l’abri de la lumière
Jour
Facteur influençant la stabilité
NaHCO3
Provoque
Précipitation
Incompatibilités
Glucose 5%
Ringer lactate
Chlorure de sodium 0,9%
Nutrition parentérale (mélange ternaire)
Voie d’administration
Intraveineuse
Perfusion continue
Bibliographie
Forme dermique
Stabilité des préparations
Origine
Excipient
Biosimilaire
Données conflictuelles
Verre
Poudre
Non précisée
Dictionnaire
www.stabilis.org - 16/01/2017 07:36 - Page 8
